# Single Ascending Dose, Multiple Ascending Dose, Food Effect Study

> **NCT06938204** · PHASE1 · COMPLETED · sponsor: **Innovo Therapeutics, Inc.** · enrollment: 48 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** INV-101
- **DRUG:** INV-101 Placebo

## Key facts

- **NCT ID:** NCT06938204
- **Lead sponsor:** Innovo Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-01
- **Primary completion:** 2024-08-09
- **Final completion:** 2024-09-13
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06938204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06938204, "Single Ascending Dose, Multiple Ascending Dose, Food Effect Study". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06938204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*